The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
Akzo Nobel N.V.
(Ink and Adhesive Resins business) Advised Akzo Nobel N.V., a global leader in coatings, chemicals and healthcare on the sale of its Ink and Adhesive Resins business to Hexion Specialty Chemicals Inc
Refco Inc.
Advised Refco Inc. on the sale of substantially all of the assets of Refco's regulated commodities futures business to Man Financial
Refco
Acted as the exclusive financial advisor to Refco Inc. in connection with its Chapter 11 proceedings which included the sale of substantially all of the assets of Refco's regulated commodities futures business to Man Financial for $1.2 billion
AEA Technology plc
Advised AEA Technology plc, a UK provider of Rail and Environmental services, on the sale of a portfolio of non-core businesses to Coller Capital. The sale formed part of a wider financial restructuring plan
7-Eleven, Inc.
Advised the special committee of 7-Eleven, Inc. in connection with its evaluation of an unsolicited tender offer commenced by Seven-Eleven Japan Co., Ltd
CP Ships Ltd
Advised TUI AG, Europe’s largest tourism company and a leading container shipping provider, on its acquisition of CP Ships Ltd., a leading Canadian container shipping company
Maytag Corporation
Advised Whirlpool Corporation, one of the world’s leading manufacturers of major home appliances, on its acquisition of Maytag Corporation
TeleCity Plc
Advised TeleCity plc on the recommended offer by 3i and Oak Hill Capital
Texas Genco LLC
Advised Texas Genco LLC on the sale of a fuel oil pipeline and associated storage assets to TEPPCO Partners LP
Inergy, L.P.
Provided a fairness opinion to Inergy Holdings GP, LLC regarding the Stagecoach natural gas storage acquisition
Texas Genco LLC
Advised Texas Genco LLC on the sale of natural gas storage assets to Kinder Morgan Energy Partners LP
Rothschilds Continuation Holdings
held by Royal & Sun Alliance
Advised Royal & Sun Alliance on the sale of its 21.5% shareholding in Rothschilds Continuation Holdings AG to Jardine Strategic Holdings
IIR
Advised T&F Informa on the acquisition of IIR, a leading provider of performance improvement solutions and organiser of conferences and exhibitions. The acquisition is to be financed via a rights issue of c.$570mm and a new debt facility
US Airways Group
Advised America West Holdings in connection with its merger with US Airways Group. (+Transaction value represents enterprise value of combined entity, including capitalized operating leases of $4.8 billion)
MCI Inc
Advised MCI in connection with its sale to Verizon Communications, Inc
Archipelago Holdings Inc
Provided financial advisory services and a fairness opinion to Archipelago Holdings, Inc. in its definitive merger agreement with the NYSE to create the NYSE Group, Inc
MeadWestvaco Corporation
/ Papers Business
Provided fairness opinion to the Board of Directors of MeadWestvaco Corporation on the sale of its Papers business and associated assets to Cerberus Capital Management, L.P
Deutz AG
Advised Marine Service business Deutz on the sale of its marine service business for medium and large size engines to Wärtsilä
LNR Property Corporation
Advised the Special Committee of the Board of Directors and the Board of Directors of LNR Property Corporation, one of the US’ leading real estate investment, finance and management companies, on its sale to Cerberus Capital Management, L.P. and its real estate affiliate, Blackacre Institutional Capital Management, LLC
Wella AG
Advised Wella AG, a global market leader in hair care and fragrances, on its sale to The Procter & Gamble Company
Morton’s Restaurant Group Inc.
Advised the Special Committee of Morton’s on sale of the Company.
Microsoft Corp.
Retained by the US Justice Department to advise it on the financial implications of the full range of potential remedies in the Microsoft antitrust case (US v. Microsoft).
Genetics Institute
Represented the Special Committee to the Board of Directors of Genetics Institute as AHP exercised its option to acquire the remaining 40% of Genetics Institute